RTI Expanded Use Of BioCleanse To Soft Tissues Spurred By CDC Report
This article was originally published in The Gray Sheet
Executive Summary
Regeneration Technologies, Inc. plans to be fully processing its soft tissue product lines with BioCleanse by late August